Current Assets: The sum of all assets that are classified as current, because they will provide a benefit within one year.
Lantern Pharma Inc. (LTRN) had Current Assets of $8.46M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-7.07M |
|
-- |
|
-- |
|
$3.51M |
|
$-3.51M |
|
$-3.56M |
|
$-7.07M |
|
$-7.07M |
|
$-7.07M |
|
$-7.07M |
|
$-7.07M |
|
$-7.07M |
|
$-3.51M |
|
$-3.50M |
|
12.42M |
|
12.42M |
|
$-0.57 |
|
$-0.57 |
|
| Balance Sheet Financials | |
|
Current Assets |
$8.46M |
$0.02M |
|
$0.14M |
|
$8.60M |
|
$4.32M |
|
-- |
|
$7.50M |
|
$11.82M |
|
$-3.22M |
|
$-3.22M |
|
$-3.22M |
|
12.76M |
|
| Cash Flow Statement Financials | |
$-6.71M |
|
$4.94M |
|
$3.99M |
|
$4.42M |
|
$6.66M |
|
$2.24M |
|
$0.71M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.96 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.71M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
219.82% |
|
219.82% |
|
-82.21% |
|
219.82% |
|
$-0.25 |
|
$-0.54 |
|
$-0.54 |
|